LA
EW icon

LBP AM’s Edwards Lifesciences EW Stock Holding History

LBP AM’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
131,104
+12,265
+10% +$1.03M 0.12% 159
2026
Q1 		$9.52M Sell
118,839
-9,863
-8% -$813K 0.13% 159
2025
Q4 		$11M Buy
128,702
+107,330
+502% +$8.81M 0.13% 158
2025
Q3 		$1.66M Buy
21,372
+4,271
+25% +$334K 0.02% 304
2025
Q2 		$1.34M Buy
+17,101
New +$1.28M 0.02% 302
2024
Q3 		– Sell
-24,099
Closed -$2.23M – 380
2024
Q2 		$2.23M Sell
24,099
-74
-0.3% -$6.55K 0.09% 151
2024
Q1 		$2.31M Sell
24,173
-81
-0.3% -$6.8K 0.09% 159
2023
Q4 		$1.85M Sell
24,254
-24,563
-50% -$1.71M 0.04% 272
2023
Q3 		$3.38M Buy
48,817
+18,797
+63% +$1.51M 0.08% 228
2023
Q2 		$2.83M Sell
30,020
-17,164
-36% -$1.49M 0.07% 213
2023
Q1 		$3.9M Sell
47,184
-1,626
-3% -$128K 0.1% 192
2022
Q4 		$3.64M Buy
+48,810
New +$3.76M 0.1% 195

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

LBP AM's EW Position: Q2 2026 in Review

LBP AM increased its Edwards Lifesciences (EW) stake by 10% in Q2 2026, buying an estimated $1.03M and bringing the position to 131,104 shares worth $11.9M. The position accounts for 0.12% of the portfolio, ranked #159.

LBP AM first reported a position in EW in Q4 2022 and has held it in 12 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • LBP AM held 131,104 shares of Edwards Lifesciences worth $11.9M as of Q2 2026.
  • LBP AM bought 12,265 Edwards Lifesciences shares in Q2 2026, an estimated $1.03M.
  • Edwards Lifesciences made up 0.12% of LBP AM's portfolio in Q2 2026, its #159 holding.
  • LBP AM first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 12 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.